insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
US$1,64
arrow_downward
-4,09%(-0,070) 1D
US$1,64
0,00% (0,00)
bedtimeAfter hours
Closed: 20 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
US$1,69
High
US$1,78
Low
US$1,63
Mkt. cap
253,12 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
2,68 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,63
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
Open
US$1,69
High
US$1,78
Low
US$1,63
Mkt. cap
253,12 ລ້ານ
Avg. vol.
2,24 ລ້ານ
Volume
2,68 ລ້ານ
52-wk high
US$3,94
52-wk low
US$1,63
EPS
US$-0,62
Beta
2,09
Shares outstanding
154,34 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
Dayton Daily News
·
38 ນາທີກ່ອນ
S&P 500 sinks 3.7% and the Nasdaq composite goes negative for the year
WSJ
·
11 ຊົ່ວໂມງກ່ອນ
S&P 500 Flirts With Correction
The Motley Fool
·
21 ນາທີກ່ອນ
If I Could Tell All S&P 500 Investors Just 1 Thing Right Now, It's This
Barron's
·
3 ຊົ່ວໂມງກ່ອນ
S&P 500’s Tech Sector Crosses Bear Market Threshold
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
Foundedພ.ຈ. 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com